Coronavirus Disease 2019 and Liver Injury: A Retrospective Analysis of Hospitalized Patients in New York City
Open Access
- 30 April 2021
- journal article
- research article
- Published by Xia & He Publishing in Journal of Clinical and Translational Hepatology
- Vol. 000 (000), 000
- https://doi.org/10.14218/jcth.2020.00171
Abstract
Coronavirus disease 2019 (COVID-19) is a global threat, affecting more than 100 million people and causing over 2 million deaths. Liver laboratory test abnormalities are an extrapulmonary manifestation of COVID-19, yet characterization of hepatic injury is incomplete. Our objective was to further characterize and identify causes of liver injury in patients with COVID-19.Keywords
This publication has 49 references indexed in Scilit:
- The liver in systemic disease: Sepsis and critical illnessClinical Liver Disease, 2016
- The Incidence and Outcomes of Ischemic Hepatitis: A Systematic Review with Meta-analysisThe American Journal of Medicine, 2015
- ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver InjuryThe American Journal of Gastroenterology, 2014
- Acquired Liver Injury in the Intensive Care UnitAnesthesiology, 2012
- Hypoxic hepatitisLiver International, 2011
- Management of SepsisThe New England Journal of Medicine, 2006
- Sepsis-induced cholestasisJournal of Hepatology, 2006
- Liver enzyme alteration: a guide for cliniciansCMAJ : Canadian Medical Association Journal, 2005
- Criteria of drug-induced liver disorders: Report of an International Consensus MeetingJournal of Hepatology, 1990
- Serum albuminJournal of Hepatology, 1988